Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ATP-sensitive potassium channel regulatory subunit (Sulfonylurea receptor, SUR) is a key component of the ATP-sensitive potassium channel (KATP) complex. KATP channels are hetero-octameric complexes composed of four pore-forming Kir6.x subunits and four regulatory SUR subunits, which belong to the ATP-binding cassette (ABC) transporter superfamily[2][4]. SUR subunits do not form the ion-conducting pore themselves; instead, they regulate the activity of the channel in response to intracellular ATP and ADP, thereby linking cellular metabolic status to electrical excitability[1][3]. Different SUR isoforms (SUR1, SUR2A, SUR2B) combine with Kir6.1 or Kir6.2 to form channels with distinct tissue distributions and pharmacological properties[4]. SUR1 is predominantly found in pancreatic β-cells, where its inhibition by sulfonylurea drugs stimulates insulin secretion[2][5]. SUR2 isoforms are prevalent in cardiac, skeletal, and smooth muscle, where they participate in the regulation of vascular tone and cardiac protection during ischemia[3][4]. Mutations in SUR subunits can lead to metabolic disorders, emphasizing their importance as both physiological regulators and therapeutic targets[2][4]. The SUR subunit is unique among ABC proteins in that it regulates, rather than transports, an ion channel[2].
Sulfonylureas bind to SUR subunits, promoting KATP channel closure and increasing insulin secretion; KATP channel openers bind to SUR and promote channel opening, leading to relaxation of vascular smooth muscle and reduced insulin secretion[1][5]. The regulatory subunit (SUR) undergoes Mg-nucleotide-dependent conformational changes that modulate channel activity in response to ADP[2][5].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-sensitive potassium channel regulatory subunit (Sulfonylurea receptor, SUR) (SUR).